IPF: Pirfenidone & Nintedanib as Treatment

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

“Dr. Timothy Whelan, Medical Director of the Lung Transplant Program from the Medical University of South Carolina, provides advice for two new drugs, Pirfenidone and Nintedanib, to slow the progression of IPF.”

Read more about IPF and approved therapies: http://bit.ly/1lfMsiZ

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

Esbriet, Idiopathic pulmonary fibrosis (IPF), IPF, OFEV® (nintedanib), pirfenidone, treatment

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums

Recent Posts


Recommended reading